Page last updated: 2024-10-28

ifosfamide and Carcinoma, Transitional Cell

ifosfamide has been researched along with Carcinoma, Transitional Cell in 34 studies

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research Excerpts

ExcerptRelevanceReference
" Mesna was administered intravenously at a 20% of the ifosfamide dosage before ifosfamide and orally at 40% after 4 and 8 hours from the ifosfamide infusion."6.68Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer. ( Pensa, F; Pronzato, P; Tani, F; Vaira, F; Vanoli, M; Vigani, A, 1997)
"The activity of ifosfamide in genitourinary malignancies has been documented in testicular cancer and bladder cancer."4.79The role of ifosfamide in the treatment of testicular and urothelial malignancies. ( Roth, BJ, 1996)
"High-dose ifosfamide (HD-IFX) has shown significant antitumor activity in advanced sarcoma and breast carcinoma."3.69Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basis. ( Albanell, J; Baselga, J; Bellmunt, J; Casado, S; Eres, N; Ribas, A, 1997)
"Ifosfamide (IFX) is an agent as yet unstudied in advanced urothelial carcinoma."2.68Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma. ( Bono, B; Dreicer, R; Elson, P; Knop, R; Loehrer, PJ; Richardson, RR; Witte, RS, 1997)
" Mesna was administered intravenously at a 20% of the ifosfamide dosage before ifosfamide and orally at 40% after 4 and 8 hours from the ifosfamide infusion."2.68Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer. ( Pensa, F; Pronzato, P; Tani, F; Vaira, F; Vanoli, M; Vigani, A, 1997)
" The aim of this retrospective study was to evaluate the activity and toxicity of bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer."1.40Bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer: a retrospective study of 37 cases. ( Li, Y; Shang, YM; Yang, Y; Zheng, H, 2014)
"They were 26 bladder cancers and 19 renal cell cancers."1.30Clinical application of an in vitro chemosensitivity test, the Histoculture Drug Response Assay, to urological cancers: wide distribution of inhibition rates in bladder cancer and renal cell cancer. ( Fujita, K; Hirano, Y; Suzuki, K; Ushiyama, T, 1999)
" (1) The tumor growth was inhibited by CDGP-II in all three different dosage groups (p < 0."1.29[Evaluation of the chemotherapy of a transplantable bladder tumour strain (NM-B-1) by two anti-cancer drugs in combination with a pressor agent in nude mice]. ( Akima, S; Horiuchi, K; Tsuboi, N; Yoshida, K, 1995)

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.94)18.7374
1990's13 (38.24)18.2507
2000's14 (41.18)29.6817
2010's5 (14.71)24.3611
2020's1 (2.94)2.80

Authors

AuthorsStudies
Hosomi, T1
Shibasaki, N1
Otsuka, H1
Uketa, S1
Makino, Y1
Shichiri, Y1
Li, Y1
Yang, Y1
Shang, YM1
Zheng, H1
Gakis, G1
Morgan, TM1
Daneshmand, S1
Keegan, KA1
Todenhöfer, T1
Mischinger, J1
Schubert, T1
Zaid, HB1
Hrbacek, J1
Ali-El-Dein, B1
Clayman, RH1
Galland, S1
Olugbade, K1
Rink, M1
Fritsche, HM1
Burger, M1
Chang, SS1
Babjuk, M1
Thalmann, GN1
Stenzl, A1
Efstathiou, JA1
Kobayashi, K1
Matsuyama, H1
Shimizu, K1
Fujii, N1
Inoue, R1
Yamamoto, Y1
Matsumoto, H1
Nagao, K1
Lawson, M1
Vasilaras, A1
De Vries, A1
Mactaggart, P1
Nicol, D1
Milowsky, MI1
Nanus, DM1
Maluf, FC1
Mironov, S1
Shi, W1
Iasonos, A1
Riches, J1
Regazzi, A1
Bajorin, DF5
Kitamura, H1
Taguchi, K1
Kunishima, Y1
Yanase, M1
Takahashi, A1
Shigyo, M1
Tanaka, T1
Mutoh, M1
Fukuta, F1
Masumori, N1
Tsukamoto, T2
Siefker-Radtke, AO1
Dinney, CP1
Shen, Y1
Williams, DL1
Kamat, AM1
Grossman, HB1
Millikan, RE2
Gonzalez-Angulo, AM1
Orzano, JA1
Davila, E1
Maezawa, T1
Yonese, J2
Ishii, N1
Fukui, I2
Antonelli, A1
Simeone, C1
Ferrari, V1
Tardanico, R1
Cunico, SC1
Akima, S1
Yoshida, K1
Tsuboi, N1
Horiuchi, K1
Kattan, J1
Culine, S1
Theodore, C1
Droz, JP1
Roth, BJ3
Dreicer, R2
Propert, KJ1
Einhorn, LH1
Loehrer, PJ2
Witte, RS1
Elson, P1
Bono, B1
Knop, R1
Richardson, RR1
Bellmunt, J1
Eres, N1
Ribas, A1
Casado, S1
Albanell, J1
Baselga, J1
Kyriakakis, Z1
Dimopoulos, MA1
Kostakopoulos, A1
Karayiannis, A1
Sofras, F1
Zervas, A1
Giannopoulos, A1
Dimopoulos, C1
Pronzato, P1
Vigani, A1
Pensa, F1
Vanoli, M1
Tani, F1
Vaira, F1
Müller, M1
Heicappell, R1
Steiner, U1
Goessl, C1
Miller, K1
McCaffrey, JA3
Hilton, S3
Mazumdar, M3
Kelly, WK3
Scher, HI2
Spicer, J1
Herr, H3
Higgins, G2
Kitsukawa, S1
Kinn, T1
Yoshida, T1
Izutami, T1
Ishikawa, Y1
Sweeney, CJ1
Williams, SD1
Finch, DE1
Bihrle, R1
Foster, RS1
Collins, M1
Fox, S1
Hirano, Y1
Ushiyama, T1
Suzuki, K1
Fujita, K1
Dodd, PM2
Icasiano, E2
Boyle, MG1
Edelman, MJ1
Krege, S1
Rembrink, V1
Börgermann, C1
Otto, T1
Rübben, H1
Ivanova, R1
Veselinova, T1
Marinov, E1
Ianev, N1
Tsvetkov, Ch1
Gorchev, G1
von der Maase, H1
VanderMolen, LA1
Sheehy, PF1
Dillman, RO1
Pagliaro, LC1
Tu, SM1
Williams, D1
Daliani, D1
Papandreou, CN1
Logothetis, CJ1
Yoshimoto, J1
Nasu, Y1
Akagi, T1
Obama, T1
Tsushima, T1
Ozaki, Y1
Matsumura, Y1
Ohmori, H1
Asahi, T1
Ohkita, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase I/II Trial of Sequential Doxorubicin/Gemcitabine (AG) and Ifosfamide, Paclitaxel, and Cisplatin (ITP) Chemotherapy (AG-ITP) in Patients With Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium[NCT00003105]Phase 1/Phase 230 participants (Anticipated)Interventional1997-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

5 reviews available for ifosfamide and Carcinoma, Transitional Cell

ArticleYear
Urological implications of cyclophosphamide and ifosfamide.
    Scandinavian journal of urology and nephrology, 2008, Volume: 42, Issue:4

    Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Cyclophosphamide; Cystitis; Humans; Ifosfamide;

2008
The role of ifosfamide in the treatment of testicular and urothelial malignancies.
    Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Clinical Trials as Top

1996
[Successful multidisciplinary treatment for bladder cancer with priapism. A case report].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1998, Volume: 89, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Comb

1998
New approaches to treatment of metastatic bladder cancer.
    Current oncology reports, 2000, Volume: 2, Issue:5

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemothe

2000
Current and future perspectives in advanced bladder cancer: is there a new standard?
    Seminars in oncology, 2002, Volume: 29, Issue:1 Suppl 3

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogeni

2002

Trials

15 trials available for ifosfamide and Carcinoma, Transitional Cell

ArticleYear
Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Sep-01, Volume: 27, Issue:25

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin

2009
Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group.
    Cancer science, 2011, Volume: 102, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Disease-F

2011
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.
    Cancer, 2013, Feb-01, Volume: 119, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitio

2013
Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancer.
    Cancer investigation, 1995, Volume: 13, Issue:3

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms

1995
Vinblastine, ifosfamide, and gallium nitrate--an active new regimen in patients with advanced carcinoma of the urothelium. A phase II trial of the Eastern Cooperative Oncology Group (E5892).
    Cancer, 1997, Jan-01, Volume: 79, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional

1997
Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; Drug Admin

1997
Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
    The Journal of urology, 1997, Volume: 158, Issue:2

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic A

1997
Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer.
    American journal of clinical oncology, 1997, Volume: 20, Issue:5

    Topics: Administration, Oral; Aged; Alopecia; Ambulatory Care; Antineoplastic Agents, Alkylating; Bone Marro

1997
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitio

1998
A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium.
    Cancer, 1999, Aug-01, Volume: 86, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Drug Admi

1999
Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:4

    Topics: Aged; Agranulocytosis; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic

2000
Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules.
    Cancer, 2000, Apr-01, Volume: 88, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitio

2000
Exploring sequenced chemotherapy regimens in the treatment of transitional cell carcinoma of the urothelial tract.
    European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Cyclophosph

2000
Docetaxel and ifosfamide as second line treatment for patients with advanced or metastatic urothelial cancer after failure of platinum chemotherapy: a phase 2 study.
    The Journal of urology, 2001, Volume: 165, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemot

2001
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jul-01, Volume: 20, Issue:13

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating;

2002

Other Studies

14 other studies available for ifosfamide and Carcinoma, Transitional Cell

ArticleYear
[Advanced Bladder Cancer with Multiple Pulmonary Metastases Treated with Paclitaxel/Ifosfamide/Nedaplatin Therapy : Two Case Reports].
    Hinyokika kiyo. Acta urologica Japonica, 2023, Volume: 69, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxy

2023
Bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer: a retrospective study of 37 cases.
    Indian journal of cancer, 2014, Volume: 51 Suppl 3

    Topics: Adenocarcinoma, Papillary; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined C

2014
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8

    Topics: Adenocarcinoma; Aged; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carb

2015
Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy.
    Japanese journal of clinical oncology, 2016, Volume: 46, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitio

2016
Ifosfamide-induced encephalopathy.
    Southern medical journal, 2002, Volume: 95, Issue:10

    Topics: Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; Encephalitis; Humans; Ifosfamide; M

2002
[Combination chemotherapy with ifosfamide, 5-fuluorouracil, etoposide and cisplatin for advanced urothelial cancer: the treatment results and significance of tumor marker evaluation in response assessment of chemotherapy].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2002, Volume: 93, Issue:7

    Topics: Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9

2002
Durable and complete remission of a metastatic bladder sarcomatoid carcinoma with chemotherapic and surgical treatments.
    Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2006, Volume: 78, Issue:2

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell;

2006
[Evaluation of the chemotherapy of a transplantable bladder tumour strain (NM-B-1) by two anti-cancer drugs in combination with a pressor agent in nude mice].
    Nihon Ika Daigaku zasshi, 1995, Volume: 62, Issue:1

    Topics: Angiotensin II; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cel

1995
Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basis.
    Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Bone Neoplasms; Breast Neoplasms; Carcinoma, Transitional Cell; D

1997
Side effects of chemotherapy for advanced urothelial carcinoma with etoposide and ifosfamide.
    Urologia internationalis, 1997, Volume: 59, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Etoposide; Femal

1997
Clinical application of an in vitro chemosensitivity test, the Histoculture Drug Response Assay, to urological cancers: wide distribution of inhibition rates in bladder cancer and renal cell cancer.
    Urological research, 1999, Volume: 27, Issue:6

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Drug Resistance; Drug Sc

1999
[Malignant Brenner tumor and transitional cell ovarian carcinoma--description of two cases].
    Akusherstvo i ginekologiia, 2001, Volume: 42, Issue:2

    Topics: Antineoplastic Agents; Brenner Tumor; Carcinoma, Transitional Cell; Female; Humans; Ifosfamide; Mesn

2001
Successful treatment of transitional cell carcinoma of the urethra with chemotherapy.
    Cancer investigation, 2002, Volume: 20, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Black People; California; Carcinoma, Transitio

2002
[Combination chemotherapy with cisplatin, ifosfamide and adriamycin in patients with advanced transitional cell carcinoma of the urinary tract].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:6

    Topics: Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transiti

1985